Nesina and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported as a side effect among people who take Nesina (alogliptin benzoate), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Dostinex, and have Acromegaly.

The phase IV clinical study analyzes which people have Arrhythmias when taking Nesina. It is created by eHealthMe based on reports of 2,291 people who have side effects when taking Nesina from the FDA, and is updated regularly.

What is Nesina?

Nesina has active ingredients of alogliptin benzoate. eHealthMe is studying from 2,297 Nesina users. Check the latest studies of Nesina.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,756 drugs and 4,840 conditions by eHealthMe. Check the latest studies of Arrhythmias.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 09, 2026

2,291 people reported to have side effects when taking Nesina.
Among them, 17 people (0.74%) have Arrhythmias.

Among these 17 people:

How long have people been on Nesina when they have Arrhythmias? *

What is the gender of people who have Arrhythmias when taking Nesina? *

female: 13.33 %
male: 86.67 %

What is the age of people who have Arrhythmias when taking Nesina? *

What are other drugs people take besides Nesina? *

What are other side effects people have besides Arrhythmias? *

Dizziness: 9 people, 52.94%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 47.06%
Nausea (feeling of having an urge to vomit): 7 people, 41.18%
Fatigue (feeling of tiredness): 7 people, 41.18%
Diarrhea: 7 people, 41.18%
Drug Intolerance (drug sensitivity): 6 people, 35.29%
Blood Growth Hormone Increased: 6 people, 35.29%
Nausea And Vomiting: 6 people, 35.29%
Insulin-Like Growth Factor Increased: 6 people, 35.29%
Pancreatic Disorder: 6 people, 35.29%

What are the existing conditions these people have? *

Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 6 people, 35.29%
Type 2 Diabetes: 5 people, 29.41%
Diabetes: 5 people, 29.41%
High Blood Pressure: 4 people, 23.53%
Urination - Excessive At Night: 1 person, 5.88%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 5.88%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Blood Glucose Abnormal: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Nesina and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nesina:

Nesina (2,297 reports)

Arrhythmias treatments and more:

Arrhythmias (177,908 reports)

Browse all side effects of Nesina:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arrhythmias:

Arrhythmias (2,756 drugs)

Browse all the conditions that are associated with Arrhythmias:

Arrhythmias (4,840 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on alogliptin benzoate (the active ingredients of Nesina) and Nesina (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.